| Article

In the journal Nature Machine Intelligence, a new article states, “Colonoscopy is limited by the outdated design of conventional endoscopes, which are associated with high complexity of use, cost and pain.” There are 19,000,000 procedures done each year in the United States and European Union, with...

| Article

Two scientists from the New York University College of Dentistry have received a grant of $3,900,000 to research potential targets of chronic pain. Over the next 5 years, endosomal receptors will be studied with the aim of improving the management of pain, and using fewer—or no—opioids. The...

| Article

Newswise — The National Institute of Dental and Craniofacial Research (NIDCR), part of the National Institutes of Health, has awarded NYU College of Dentistry’s Yi Ye, PhD, a $2.2 million, five-year grant to study the role of Schwann cells, the most prevalent type of cell supporting neurons in the...

| Article

Koselugo (selumetinib) has received the first approval for treatment of neurofibromatosis type 1 (NF1) in children ages 2 years and older, the U.S. Food and Drug Administration announced Friday.

Approved specifically for patients with symptomatic, inoperable plexiform neurofibromas (PNs)...

| Article

Newswise — NIBIB-funded bioengineers at the University of Illinois have combined standard microscopy, infrared light, and artificial intelligence (AI) to assemble digital biopsies that identify important molecular characteristics of cancer biopsy samples without dyes or labels.

The standard...

| Article

Cancer chemotherapy side effects, like fatigue, pain and nausea, are typically intense immediately following an infusion and gradually subside until the next treatment two to three weeks later. Although exercise can lessen the side effects, the side effects often cause patients to avoid exercise. As...

| Article

Acetaminophen has been available in the U.S. without a prescription since 1955. Concerns about its potential link to cancer come from its relationship to another drug: phenacetin. That drug, once a common treatment for headaches and other ailments, was banned by the FDA in 1983 because it caused...

| Article

Newswise — Many people under 60 who develop stomach cancer have a "genetically and clinically distinct" disease, new Mayo Clinic research has discovered. Compared to stomach cancer in older adults, this new, early onset form often grows and spreads more quickly, has a worse prognosis, and is more...

| Article

Newswise — An experimental, off-the-shelf immunotherapy that combines a targeted antibody and chemotherapy can lead to potentially durable responses in multiple myeloma patients whose disease has relapsed or is resistant to other standard therapies. A multi-center, international trial evaluated the...

| Article

Newswise — Opioids play an important role in how cancer patients manage pain, but the ongoing opioid epidemic has raised concerns about their potential for abuse.

Pain remains one of the most difficult symptoms associated with cancer. More than half of cancer patients undergoing treatment...

Subscribe to cancer

Sign-Up